A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study
J Am Acad Dermatol
.
2024 Dec;91(6):1258-1260.
doi: 10.1016/j.jaad.2024.07.1513.
Epub 2024 Sep 7.
Authors
Taoming Liu
1
,
Manman Tang
1
,
Jiao Liu
1
,
Tinghui Kong
1
,
Yuyang Tian
1
,
Sai Yang
1
,
Jiao Zhang
1
,
Suyun Ji
1
,
Zhimiao Lin
1
,
Ruzeng Xue
1
,
Yan Ding
2
,
Bin Yang
3
,
Yunsheng Liang
4
Affiliations
1
Dermatology Hospital, Southern Medical University, Guangzhou, People's Republic of China.
2
Department of Dermatology, Hainan Provincial Hospital of Skin Disease, Haikou, People's Republic of China.
3
Dermatology Hospital, Southern Medical University, Guangzhou, People's Republic of China. Electronic address: yangbin1@smu.edu.cn.
4
Dermatology Hospital, Southern Medical University, Guangzhou, People's Republic of China. Electronic address: yunshengliang@aliyun.com.
PMID:
39182676
DOI:
10.1016/j.jaad.2024.07.1513
No abstract available
Keywords:
Netherton syndrome; combination therapy; dupilumab; secukinumab.